Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Leukemia 34Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Lymphoma 27Burkitt Lymphoma 27Lymphoma, Non-Hodgkin 22Lymphoma, Large B-Cell, Diffuse 22Myelodysplastic Syndromes 20Leukemia, Myeloid, Chronic-Phase 20Lymphoma, Follicular 19Leukemia, Lymphocytic, Chronic, B-Cell 18Leukemia, Myeloid, Accelerated Phase 17Multiple Myeloma 16Lymphoma, Large-Cell, Immunoblastic 15Blast Crisis 15Myeloproliferative Disorders 14Leukemia, Myeloid, Acute 14Dendritic Cell Sarcoma, Interdigitating 14Recurrence 13Lymphoma, Mantle-Cell 13Lymphoma, B-Cell, Marginal Zone 13Graft vs Host Disease 13Leukemia, Myelomonocytic, Chronic 12Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 12Hodgkin Disease 11Congenital Abnormalities 11Neoplasms, Plasma Cell 10Myelodysplastic-Myeloproliferative Diseases 10Anemia, Refractory, with Excess of Blasts 9Primary Myelofibrosis 8Lymphoma, Large-Cell, Anaplastic 8

Interventions

Octreotide 3Metoclopramide 1Methylprednisolone 1Dexamethasone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Intestinal Obstruction × Methylprednisolone × Clear all
NCT00332696 2011-09-23

Octreotide Compared to Placebo in Patients With Inoperable Bowel Obstruction Due to Peritoneal Carcinomatosis

Novartis

Phase 2 Completed
64 enrolled 17 charts
Gynecologic

Carcinoma, Intestinal Obstruction, Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡